Form 4: Pharvaris CMO Peng Lu Reports Tax-Related Share Withholding

Chief Medical Officer Peng Lu disposed of 117 shares of Pharvaris N.V. to satisfy tax obligations related to RSU vesting.

Summary

• Peng Lu, Chief Medical Officer of Pharvaris N.V., reported the withholding of 117 shares of common stock.
• The transaction occurred on June 12, 2026, at a price of $32.20 per share.
• The withholding was executed to satisfy tax obligations associated with the vesting of restricted stock units.
• Following this transaction, Peng Lu maintains beneficial ownership of 65,631 shares of Pharvaris common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a mandatory administrative filing regarding tax obligations rather than a strategic or market-driven trade.

Positives

• The transaction is a routine administrative action related to tax withholding upon equity vesting, rather than a discretionary market sale.

Negatives

• The transaction represents a minor reduction in the reporting person's total shareholdings.

Risks

• None identified; this is a standard regulatory disclosure for executive compensation tax compliance.

Future Outlook

Not applicable; this is a historical disclosure of an insider transaction.

Industry Context

StockSavvy.ai notes that routine tax-related share withholdings by executives are standard industry practice and do not typically signal changes in management sentiment or company outlook.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for equity-based compensation in the biotechnology sector.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine tax-related withholding.

Key Dates

Keywords

Pharvaris, PHVS, Form 4, Insider Trading, Chief Medical Officer, Equity Vesting